Disease burden of herpes zoster in Korea

Wonseok Choi, Ji Yun Noh, Joong Yeon Huh, Yu Mi Jo, Jacob Lee, Joon-Young Song, Woo Joo Kim, Hee-Jin Cheong

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The occurrence of herpes zoster can deteriorate the quality of life considerably, resulting in high disease burden. While Korea is assumed to have high disease burden of herpes zoster, there has been no researches analyzing this. Objectives: We performed this study to investigate the disease burden of herpes zoster in the Korean population as a whole. Study design: We used the database of the Health Insurance Review & Assessment Service of Korea and analyzed the data of patients who had herpes zoster as a principal diagnosis during the period from 2003 to 2007. We investigated the annual prevalence, rate of clinical visits, rate of hospitalization, and the pattern of medical services use. The socioeconomic burden of herpes zoster was calculated by a conversion into cost. Results: Rates of clinic visits and hospitalizations due to herpes zoster during the 5-year period from 2003 to 2007 were 7.93-12.54 per 1000 population and 0.22-0.32 per 1000 population, respectively. Prevalence rates according to age increased sharply after 50 years and reached a peak at 70 years. The total socioeconomic cost of herpes zoster was $75.9-143.8 million per year, increasing every year by 14-20%. Conclusions: There is a heavy socioeconomic burden due to herpes zoster in Korea and indicate that appropriate policies need to be established to reduce this burden. Additional researches are also necessary to assess the safety, efficacy and cost-effectiveness of a herpes zoster vaccine in the Korean population.

Original languageEnglish
Pages (from-to)325-329
Number of pages5
JournalJournal of Clinical Virology
Volume47
Issue number4
DOIs
Publication statusPublished - 2010 Apr 1

Fingerprint

Herpes Zoster
Korea
Population
Hospitalization
Herpes Zoster Vaccine
Costs and Cost Analysis
Health Insurance
Ambulatory Care
Research
Cost-Benefit Analysis
Quality of Life
Databases
Safety

Keywords

  • Disease burden
  • Herpes zoster
  • Varicella zoster virus

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Disease burden of herpes zoster in Korea. / Choi, Wonseok; Noh, Ji Yun; Huh, Joong Yeon; Jo, Yu Mi; Lee, Jacob; Song, Joon-Young; Kim, Woo Joo; Cheong, Hee-Jin.

In: Journal of Clinical Virology, Vol. 47, No. 4, 01.04.2010, p. 325-329.

Research output: Contribution to journalArticle

@article{d298f7ddfa044875b6766e8f17e39f0b,
title = "Disease burden of herpes zoster in Korea",
abstract = "Background: The occurrence of herpes zoster can deteriorate the quality of life considerably, resulting in high disease burden. While Korea is assumed to have high disease burden of herpes zoster, there has been no researches analyzing this. Objectives: We performed this study to investigate the disease burden of herpes zoster in the Korean population as a whole. Study design: We used the database of the Health Insurance Review & Assessment Service of Korea and analyzed the data of patients who had herpes zoster as a principal diagnosis during the period from 2003 to 2007. We investigated the annual prevalence, rate of clinical visits, rate of hospitalization, and the pattern of medical services use. The socioeconomic burden of herpes zoster was calculated by a conversion into cost. Results: Rates of clinic visits and hospitalizations due to herpes zoster during the 5-year period from 2003 to 2007 were 7.93-12.54 per 1000 population and 0.22-0.32 per 1000 population, respectively. Prevalence rates according to age increased sharply after 50 years and reached a peak at 70 years. The total socioeconomic cost of herpes zoster was $75.9-143.8 million per year, increasing every year by 14-20{\%}. Conclusions: There is a heavy socioeconomic burden due to herpes zoster in Korea and indicate that appropriate policies need to be established to reduce this burden. Additional researches are also necessary to assess the safety, efficacy and cost-effectiveness of a herpes zoster vaccine in the Korean population.",
keywords = "Disease burden, Herpes zoster, Varicella zoster virus",
author = "Wonseok Choi and Noh, {Ji Yun} and Huh, {Joong Yeon} and Jo, {Yu Mi} and Jacob Lee and Joon-Young Song and Kim, {Woo Joo} and Hee-Jin Cheong",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.jcv.2010.01.003",
language = "English",
volume = "47",
pages = "325--329",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Disease burden of herpes zoster in Korea

AU - Choi, Wonseok

AU - Noh, Ji Yun

AU - Huh, Joong Yeon

AU - Jo, Yu Mi

AU - Lee, Jacob

AU - Song, Joon-Young

AU - Kim, Woo Joo

AU - Cheong, Hee-Jin

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Background: The occurrence of herpes zoster can deteriorate the quality of life considerably, resulting in high disease burden. While Korea is assumed to have high disease burden of herpes zoster, there has been no researches analyzing this. Objectives: We performed this study to investigate the disease burden of herpes zoster in the Korean population as a whole. Study design: We used the database of the Health Insurance Review & Assessment Service of Korea and analyzed the data of patients who had herpes zoster as a principal diagnosis during the period from 2003 to 2007. We investigated the annual prevalence, rate of clinical visits, rate of hospitalization, and the pattern of medical services use. The socioeconomic burden of herpes zoster was calculated by a conversion into cost. Results: Rates of clinic visits and hospitalizations due to herpes zoster during the 5-year period from 2003 to 2007 were 7.93-12.54 per 1000 population and 0.22-0.32 per 1000 population, respectively. Prevalence rates according to age increased sharply after 50 years and reached a peak at 70 years. The total socioeconomic cost of herpes zoster was $75.9-143.8 million per year, increasing every year by 14-20%. Conclusions: There is a heavy socioeconomic burden due to herpes zoster in Korea and indicate that appropriate policies need to be established to reduce this burden. Additional researches are also necessary to assess the safety, efficacy and cost-effectiveness of a herpes zoster vaccine in the Korean population.

AB - Background: The occurrence of herpes zoster can deteriorate the quality of life considerably, resulting in high disease burden. While Korea is assumed to have high disease burden of herpes zoster, there has been no researches analyzing this. Objectives: We performed this study to investigate the disease burden of herpes zoster in the Korean population as a whole. Study design: We used the database of the Health Insurance Review & Assessment Service of Korea and analyzed the data of patients who had herpes zoster as a principal diagnosis during the period from 2003 to 2007. We investigated the annual prevalence, rate of clinical visits, rate of hospitalization, and the pattern of medical services use. The socioeconomic burden of herpes zoster was calculated by a conversion into cost. Results: Rates of clinic visits and hospitalizations due to herpes zoster during the 5-year period from 2003 to 2007 were 7.93-12.54 per 1000 population and 0.22-0.32 per 1000 population, respectively. Prevalence rates according to age increased sharply after 50 years and reached a peak at 70 years. The total socioeconomic cost of herpes zoster was $75.9-143.8 million per year, increasing every year by 14-20%. Conclusions: There is a heavy socioeconomic burden due to herpes zoster in Korea and indicate that appropriate policies need to be established to reduce this burden. Additional researches are also necessary to assess the safety, efficacy and cost-effectiveness of a herpes zoster vaccine in the Korean population.

KW - Disease burden

KW - Herpes zoster

KW - Varicella zoster virus

UR - http://www.scopus.com/inward/record.url?scp=77949491655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949491655&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2010.01.003

DO - 10.1016/j.jcv.2010.01.003

M3 - Article

VL - 47

SP - 325

EP - 329

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 4

ER -